Cargando…

Pulmonary Hypertension in Parenchymal Lung Disease

Idiopathic pulmonary arterial hypertension (IPAH) has been extensively investigated, although it represents a less common form of the pulmonary hypertension (PH) family, as shown by international registries. Interestingly, in types of PH that are encountered in parenchymal lung diseases such as inte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsangaris, Iraklis, Tsaknis, Georgios, Anthi, Anastasia, Orfanos, Stylianos E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474989/ https://www.ncbi.nlm.nih.gov/pubmed/23094153 http://dx.doi.org/10.1155/2012/684781

Ejemplares similares

The Role of Exercise Doppler Echocardiography to Unmask Pulmonary Arterial Hypertension in Selected Patients with Systemic Sclerosis and Equivocal Baseline Echocardiographic Values for Pulmonary Hypertension
por: Rallidis, Loukianos S., et al.
Publicado: (2021)

Cardiac Catheterization versus Echocardiography for Monitoring Pulmonary Pressure: A Prospective Study in Patients with Connective Tissue Disease-Associated Pulmonary Arterial Hypertension
por: Bournia, Vasiliki Kalliopi, et al.
Publicado: (2020)

Post-operative Aspergillus mediastinitis in a man who was immunocompetent: a case report
por: Dimopoulos, George, et al.
Publicado: (2010)

Low-Dose Dobutamine Stress Echocardiography for the Early Detection of Pulmonary Arterial Hypertension in Selected Patients with Systemic Sclerosis Whose Resting Echocardiography Is Non-Diagnostic for Pulmonary Hypertension
por: Rallidis, Loukianos S., et al.
Publicado: (2021)

Incidence and outcomes of COVID-19 in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Data from the Hellenic pulmOnary hyPertension rEgistry (HOPE)
por: Farmakis, Ioannis T., et al.
Publicado: (2022)

Pulmonary Arterial Hypertension in Connective Tissue Disorders: The emerging role of screening and early diagnosis. A position paper for Greek Rheumatologists
por: Demerouti, Eftychia, et al.
Publicado: (2019)

Clinical Usefulness of Novel Serum and Imaging Biomarkers in Risk Stratification of Patients with Stable Angina
por: Tsaknis, George, et al.
Publicado: (2014)

The wide spectrum of β-thalassaemia intermedia-induced pulmonary hypertension: two case reports on the possible role of specific pulmonary arterial hypertension therapy
por: Anthi, Anastasia, et al.
Publicado: (2021)

Life-threatening aortic thrombosis in a trauma patient homozygous for factor V Leiden mutation: Case report
por: Tsangaris, Iraklis, et al.
Publicado: (2011)

Coagulation Profiles of Pulmonary Arterial Hypertension Patients, Assessed by Non-Conventional Hemostatic Tests and Markers of Platelet Activation and Endothelial Dysfunction
por: Vrigkou, Eleni, et al.
Publicado: (2020)

The impact of cardiovascular comorbidities associated with risk for left heart disease on idiopathic pulmonary arterial hypertension: Data from the Hellenic Pulmonary Hypertension Registry (HOPE)
por: Arvanitaki, Alexandra, et al.
Publicado: (2022)

Epidemiology and initial management of pulmonary arterial hypertension: real-world data from the Hellenic pulmOnary hyPertension rEgistry (HOPE)
por: Arvanitaki, Alexandra, et al.
Publicado: (2019)

Diagnostic and prognostic value of procalcitonin among febrile critically ill patients with prolonged ICU stay
por: Tsangaris, Iraklis, et al.
Publicado: (2009)

Epidemiology and Management of Chronic Thromboembolic Pulmonary Hypertension in Greece. Real-World Data from the Hellenic Pulmonary Hypertension Registry (HOPE)
por: Demerouti, Eftychia, et al.
Publicado: (2021)

Preclinical pulmonary capillary endothelial dysfunction is present in brain dead subjects
por: Glynos, Constantinos, et al.
Publicado: (2013)

Is pulmonary arterial hypertension associated with interferon-β therapy for multiple sclerosis reversible? A case study to explore the complexity
por: Anthi, Anastasia, et al.
Publicado: (2020)

Angiopoietin-2 Levels as Predictors of Outcome in Mechanically Ventilated Patients with Acute Respiratory Distress Syndrome
por: Tsangaris, Iraklis, et al.
Publicado: (2017)

Balloon Pulmonary Angioplasty in Patients with Chronic Thromboembolic Pulmonary Hypertension in Greece: Data from the Hellenic Pulmonary Hypertension Registry
por: Karyofyllis, Panagiotis, et al.
Publicado: (2022)

Prematurity and Pulmonary Vein Stenosis: The Role of Parenchymal Lung Disease and Pulmonary Vascular Disease
por: Vyas-Read, Shilpa, et al.
Publicado: (2022)

DIFFUSE PARENCHYMAL LUNG DISEASE AND PULMONARY CIRCULATION
Publicado: (2022)

Diffuse Parenchymal Lung Disease and Pulmonary Circulation
Publicado: (2022)

Pulmonary Hypertension due to Lung Diseases and/or Hypoxia: What Do We Actually Know?
por: Kosanovic, Djuro, et al.
Publicado: (2017)

Angiotensin-converting enzyme (ACE) insertion/deletion polymorphism and circulating ACE levels are not associated with outcome in septic critically ill patients
por: Tsangaris, I, et al.
Publicado: (2011)

Vasodilator responsiveness in idiopathic pulmonary arterial hypertension: identifying a distinct phenotype with distinct physiology and distinct prognosis
por: Langleben, David, et al.
Publicado: (2017)

Lower DLco% identifies exercise pulmonary hypertension in patients with parenchymal lung disease referred for dyspnea
por: Zou, Richard H., et al.
Publicado: (2020)

Diffuse parenchymal lung disease
por: Tomassetti, Sara, et al.
Publicado: (2017)

A syndrome of severe idiopathic pulmonary parenchymal disease with pulmonary hypertension in Pekingese
por: Köster, Liza S, et al.
Publicado: (2016)

Pulmonary Hypertension: Current Diagnosis, Approach and Treatment at the Dawn of the New European Guidelines
por: Orfanos, Stylianos E., et al.
Publicado: (2022)

Genetic testing in diffuse parenchymal lung disease
por: Spagnolo, Paolo, et al.
Publicado: (2012)

Parenchymal Sparing Surgery for Lung Cancer: Focus on Pulmonary Artery Reconstruction
por: Menna, Cecilia, et al.
Publicado: (2022)

Pulmonary capillary recruitment and distention in mammalian lungs: species similarities
por: Langleben, David, et al.
Publicado: (2022)

Computed tomography lung parenchymal descriptions in routine radiological reporting have diagnostic and prognostic utility in patients with idiopathic pulmonary arterial hypertension and pulmonary hypertension associated with lung disease
por: Dwivedi, Krit, et al.
Publicado: (2022)

Platelet, Fibrinolytic and Other Coagulation Abnormalities in Newly-Diagnosed Patients with Chronic Thromboembolic Pulmonary Hypertension
por: Vrigkou, Eleni, et al.
Publicado: (2022)

Efficacy of Inhaled Treprostinil on Multiple Disease Progression Events in Patients with Pulmonary Hypertension due to Parenchymal Lung Disease in the INCREASE Trial
por: Nathan, Steven D., et al.
Publicado: (2021)

An Immune Basis for Lung Parenchymal Destruction in Chronic Obstructive Pulmonary Disease and Emphysema
por: Grumelli, Sandra, et al.
Publicado: (2004)

Non-infectious Parenchymal Lung Disease
por: Dalpiaz, G., et al.
Publicado: (2016)

Relevance of Autophagy in Parenchymal and Non-Parenchymal Liver Cells for Health and Disease
por: Weiskirchen, Ralf, et al.
Publicado: (2019)

Behçet’s Disease: A Radiological Review of Vascular and Parenchymal Pulmonary Involvement
por: Giannessi, Caterina, et al.
Publicado: (2022)

Epigenetic Mechanisms in Parenchymal Lung Diseases: Bystanders or Therapeutic Targets?
por: Avci, Edibe, et al.
Publicado: (2022)

Mechanistic Understanding of Lung Inflammation: Recent Advances and Emerging Techniques
por: Keskinidou, Chrysi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5qo5edou8ljhq5vnegi7sqgid0